NCT00799110 Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod Status TERMINATED Phase PHASE2
NCT00794911 Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation Status COMPLETED Phase NA
NCT00792428 Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery Status COMPLETED Phase NA
NCT00788775 Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma Status COMPLETED Phase PHASE2
NCT00785265 A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation Status COMPLETED Phase NA
NCT00782275 Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00780962 N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients Status COMPLETED Phase PHASE2
NCT00776594 Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy Status COMPLETED Phase PHASE2
NCT00768144 Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma Status COMPLETED Phase PHASE2
NCT00766467 A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Status COMPLETED Phase PHASE2
NCT00749320 Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC) Status COMPLETED Phase NA
NCT00734136 Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome Status TERMINATED Phase NA
NCT00721370 Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer Status COMPLETED Phase PHASE1
NCT00719134 The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache Status COMPLETED Phase PHASE4
NCT00711035 Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) Status COMPLETED Phase PHASE1/PHASE2
NCT00697684 Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant Status COMPLETED Phase PHASE1